News - December 17, 2020

EMA & HMA Joint Strategy 2021-2025

Published on 8 December, the European Medicines Agency (EMA) and Heads of Medicines Agency (HMA) Joint Strategy looks into six strategic focus areas: (1) Availability and accessibility of medicines, (2) Digital tools and digital transformation, (3) Innovation, (4) Antimicrobial resistance, (5) Supply chain challenges, and… read more

EUCOPE Resources / News / Press Releases - November 25, 2020

EC Pharmaceutical Strategy – Time for a Modern Approach to Value

EUCOPE, the European association for small to medium-sized companies active in pharmaceuticals and biotechnologies – many of which are researching and developing rare disease treatments – notes the publication of the European Commission Communication on the Pharmaceutical Strategy for Europe. EUCOPE calls for a comprehensive Pharmaceutical Strategy… read more

News - November 24, 2020

Join us: RARE Conversations Breakfast Briefing

RARE Conversations Breakfast Briefing Impact of COVID-19 on Pharmaceutical Research and Development in Rare Diseases 3 December 2020 | 10.00 – 11.15 CET via Zoom   Europe has long been at the forefront in healthcare and is home to many leading healthcare professionals, academia and… read more